US 10799584
Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10799584 (Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K31/4745